Bavarian Nordic A/S (BAVA.CO) Key Developments | Reuters.com
Edition:
United States

Bavarian Nordic A/S (BAVA.CO)

BAVA.CO on Copenhagen Stock Exchange

218.50DKK
10:59am EDT
Change (% chg)

kr.9.00 (+4.30%)
Prev Close
kr.209.50
Open
kr.214.50
Day's High
kr.218.50
Day's Low
kr.214.00
Volume
150,196
Avg. Vol
195,754
52-wk High
kr.368.00
52-wk Low
kr.197.00

Latest Key Developments (Source: Significant Developments)

Bavarian Nordic: Expansion of IMVAMUNE orders from Canada
Wednesday, 15 Jun 2016 09:04am EDT 

Bavarian Nordic A/S : Announces expansion of IMVAMUNE orders from Canadian government . Canadian government exercised option for supply of 171,000 doses of IMVAMUNE smallpox vaccine to national stockpile at total value of $7.7 million .Says contents of this announcement do not affect company's expectations for financial results for 2016.  Full Article

Bavarian Nordic Q1 EBIT loss increases to DKK 153 million
Friday, 13 May 2016 01:47am EDT 

Bavarian Nordic A/S : Q1 revenue 23 million Danish crowns ($3.52 million) versus 235 million crowns year ago . Q1 EBIT loss 153 million crowns versus loss 40 million crowns year ago .Maintains its financial expectations for 2016.  Full Article

Bavarian Nordic A/S: Positive data for Ebola vaccine regimen
Monday, 18 Apr 2016 06:00pm EDT 

Bavarian Nordic A/S:Results of Phase 1 study of a preventive Ebola vaccine regimen suggest that regimen was well-tolerated by healthy volunteers and did not result in any vaccine-related serious adverse events.Study tested vaccine regimen containing two components, of which one was based on MVA-BN technology from Bavarian Nordic.Confirmed data from a Phase 1 study of a preventive Ebola vaccine regimen have been published in The Journal of the American Medical Association.  Full Article

Bavarian Nordic completes a private placement at market price
Monday, 18 Apr 2016 02:03am EDT 

Bavarian Nordic A/S:Completes a private placement at market price.Says subscription price is 240 Danish crowns per share.Raises gross proceeds in private placement of about 665 million crowns.Raises expectations to FY 2016 year-end cash preparedness to level of 1.90 billion crowns from 1.30 billion crowns.  Full Article

Bavarian Nordic A/S to raise up to 665 million crowns in private placement
Thursday, 14 Apr 2016 01:13am EDT 

Bavarian Nordic A/S:Resolved to launch an offering of up to 2.8 million shares.Offer price of 240 Danish crowns per share has been determined through accelerated bookbuilding process.To raise gross proceeds of up to about 665 million Danish crowns.Said the offering represents up to 9.87 percent of Bavarian Nordic's registered share capital.Expects to use proceeds to accelerate commercial vaccine pipeline.Maintains 2016 financial outlook - revenue at level of 1.00 billion crowns and a break-even result before interest and tax (EBIT).  Full Article

Bavarian Nordic A/S gives FY 2016 revenue and EBIT guidance
Monday, 7 Mar 2016 06:50am EST 

Bavarian Nordic A/S:In FY 2016, expects revenue at level of 1,000 million Danish crowns.Sees a break-even result before interest and tax (EBIT) in FY 2016.  Full Article

Bavarian Nordic enters research collaboration to develop MRSA vaccine
Thursday, 4 Feb 2016 01:31am EST 

Bavarian Nordic A/S:‍Has entered into a joint collaboration with Evaxion Biotech and Technical University of Denmark for development of an MVA-BN-based vaccine against MRSA​.‍Intends to engineer and produce a recombinant MVA-BN-based vaccine candidate​.‍If proven safe and efficacious, human trials could occur in 2019​.‍Project has received initial funding from Innovation Fund Denmark in amount of 17 million Danish crowns.  Full Article

Bavarian Nordic files for U.S. IPO of up to $86.3 mln - SEC filing
Monday, 4 Jan 2016 11:55am EST 

Bavarian Nordic A/S:Files for U.S. IPO of up to $86.3 million - SEC filing.Says it has applied to list its ads on NASDAQ under the symbol "bavn".Cowen and co, Piper Jaffray and nomura are underwriters to IPO.IPO size estimated solely for purpose of calculating the registration fee.  Full Article

Bavarian Nordic files registration statement for U.S. ADS IPO
Monday, 4 Jan 2016 09:05am EST 

Bavarian Nordic A/S:Files registration statement for proposed Initial Public Offering of American Depositary Shares ("ADSs") in the United States.‍Proposed offering, if made, to increase its share capital by up to 2.8 million shares of 10 Danish crowns each.  Full Article

Bavarian Nordic A/S enters agreement with Janssen for MVA-BN
Friday, 18 Dec 2015 01:30am EST 

Bavarian Nordic A/S:Enters licensing and collaboration agreement with Janssen for MVA-BN in the development of a therapeutic HPV vaccine​.‍Total potential agreement value $171 million.Janssen will fund all development costs, and Bavarian Nordic will undertake all manufacturing related to MVA-BN.  Full Article